Ophthalmic formulations of Amyloidbeta contrast agents and methods of use thereof

Details for Australian Patent Application No. 2008254428 (hide)

Owner Neuroptix Corporation

Inventors Sherr, Evan A.; Smith, Francis X.; Sullivan, Kevin R.; Goldstein, Lee E.; Hartung, Paul D.

Agent Cullens

Pub. Number AU-A-2008254428

PCT Pub. Number WO2008/144065

Priority 61/062,170 23.01.08 US; 60/931,189 21.05.07 US

Filing date 21 May 2008

Wipo publication date 27 November 2008

International Classifications

A61K 31/05 (2006.01)

A61K 31/085 (2006.01)

A61K 31/194 (2006.01)

A61K 31/216 (2006.01)

A61K 49/00 (2006.01) Preparations for testing

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2008/144065 Priority application(s): WO2008/144065

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008254434-Configurable gaming machine permitting multiple appearaces and facilitating component accessibility

2008254425-CSF-1R inhibitors, compositions, and methods of use